Table 3. Antimicrobial testing of N_lysN_lysN_lys based lipopeptoids.

Compound Organism	CTAC	C11-NlysNlysNlys	C14-NlysNlysNlys	C16-NlysNlysNlys	C20-NlysNlysNlys	F11-NlysNlysNlys	C11-NhargNhargNharg	C14-NhargNhargNharg	C16-NhargNhargNharg	C20-NhargNhargNharg
S.aureus b	1	512	32	16	16	32	128	16	8	8
MRSA c	1	512	64	32	16	32	128	16	16	16
MSSE d	0.5	512	32	8	8	32	64	8	8	8
MRSE e	2	512	16	8	8	32	256	16	8	8
E. faecalis f	1	512	64	32	16	64	512	32	16	16
E. faecium g	0.5	256	64	32	16	64	256	16	16	8
S.pneumoniae h	2	>512	128	128	64	128	512	64	64	64
E.coli i	16	>512	128	32	32	64	>512	64	16	64
E.coli j	32	>512	128	64	32	64	>512	64	32	64
E.coli k	16	>512	128	64	32	128	>512	64	32	32
P.aeruginosa l	128	>512	512	128	128	128	>512	256	64	128
P.aeruginosa m	64	>512	512	128	64	256	>512	128	64	128
S. maltophilia n	32	>512	>512	256	64	>512	>512	256	128	64
A. baumannii o	32	>512	512	256	64	>512	>512	256	128	64
K.pneumoniae p	16	>512	512	128	64	>512	>512	256	256	64
Haemolysis	77.05	0.67	2.19	67.69	68.29	8.13	0.71	20.34	30.80	71.50

^aMIC, reported in µg/mL.

^bATCC 29213.

^cATCC 33592.

^d81388 CANWARD 2008.

^eCAN-ICU 61589.

^fATCC 29212.

^gATCC 27270.

^hATCC 49619.

ⁱATCC 25922.

^jCAN-ICU 61714.

^kCAN-ICU 63074.

^lATCC 27853.

^mCAN-ICU 62308.

ⁿCAN-ICU 62584.

^oCAN-ICU 63169.

^pATCC 13883.

^qPercent haemolysis at 100µg/mL of compound.